Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Clinical trial NCT00020748 · COMPLETED

Trial details

NCT number: NCT00020748
Sponsor: Georgetown University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2000-08-01
Primary completion: 2004-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.